139 related articles for article (PubMed ID: 38689257)
1. Access to quality-assured artemisinin-based combination therapy and associated factors among clients of selected private drug outlets in Uganda.
Ocan M; Nakalembe L; Otike C; Mordecai T; Birungi J; Nsobya S
Malar J; 2024 Apr; 23(1):128. PubMed ID: 38689257
[TBL] [Abstract][Full Text] [Related]
2. Copayment mechanism in selected districts of Uganda: Availability, market share and price of quality assured artemisinin-based combination therapies in private drug outlets.
Ocan M; Nambatya W; Otike C; Nakalembe L; Nsobya S
PLoS One; 2024; 19(3):e0295198. PubMed ID: 38536824
[TBL] [Abstract][Full Text] [Related]
3. Experience of healthcare personnel on Co-payment mechanism and the implications on its use in private drug outlets in Uganda.
Ocan M; Bakubi R; Nakalembe L; Ekusai-Sebatta D; Sam N
PLoS One; 2024; 19(5):e0297416. PubMed ID: 38758832
[TBL] [Abstract][Full Text] [Related]
4. Artemisinin-based combination therapy availability and use in the private sector of five AMFm phase 1 countries.
Davis B; Ladner J; Sams K; Tekinturhan E; de Korte D; Saba J
Malar J; 2013 Apr; 12():135. PubMed ID: 23607504
[TBL] [Abstract][Full Text] [Related]
5. What happened to anti-malarial markets after the Affordable Medicines Facility-malaria pilot? Trends in ACT availability, price and market share from five African countries under continuation of the private sector co-payment mechanism.
; Tougher S; Hanson K; Goodman C
Malar J; 2017 Apr; 16(1):173. PubMed ID: 28441956
[TBL] [Abstract][Full Text] [Related]
6. Private sector role, readiness and performance for malaria case management in Uganda, 2015.
; Kaula H; Buyungo P; Opigo J
Malar J; 2017 May; 16(1):219. PubMed ID: 28545583
[TBL] [Abstract][Full Text] [Related]
7. Treatment-seeking patterns for malaria in pharmacies in five sub-Saharan African countries.
Ladner J; Davis B; Audureau E; Saba J
Malar J; 2017 Aug; 16(1):353. PubMed ID: 28851358
[TBL] [Abstract][Full Text] [Related]
8. The malaria testing and treatment landscape in Kenya: results from a nationally representative survey among the public and private sector in 2016.
; Musuva A; Ejersa W; Kiptui R; Memusi D; Abwao E
Malar J; 2017 Dec; 16(1):494. PubMed ID: 29268789
[TBL] [Abstract][Full Text] [Related]
9. Got ACTs? Availability, price, market share and provider knowledge of anti-malarial medicines in public and private sector outlets in six malaria-endemic countries.
O'Connell KA; Gatakaa H; Poyer S; Njogu J; Evance I; Munroe E; Solomon T; Goodman C; Hanson K; Zinsou C; Akulayi L; Raharinjatovo J; Arogundade E; Buyungo P; Mpasela F; Adjibabi CB; Agbango JA; Ramarosandratana BF; Coker B; Rubahika D; Hamainza B; Chapman S; Shewchuk T; Chavasse D
Malar J; 2011 Oct; 10():326. PubMed ID: 22039838
[TBL] [Abstract][Full Text] [Related]
10. Closing the access barrier for effective anti-malarials in the private sector in rural Uganda: consortium for ACT private sector subsidy (CAPSS) pilot study.
Talisuna AO; Daumerie PG; Balyeku A; Egan T; Piot B; Coghlan R; Lugand M; Bwire G; Rwakimari JB; Ndyomugyenyi R; Kato F; Byangire M; Kagwa P; Sebisubi F; Nahamya D; Bonabana A; Mpanga-Mukasa S; Buyungo P; Lukwago J; Batte A; Nakanwagi G; Tibenderana J; Nayer K; Reddy K; Dokwal N; Rugumambaju S; Kidde S; Banerji J; Jagoe G
Malar J; 2012 Oct; 11():356. PubMed ID: 23107021
[TBL] [Abstract][Full Text] [Related]
11. Testing times: trends in availability, price, and market share of malaria diagnostics in the public and private healthcare sector across eight sub-Saharan African countries from 2009 to 2015.
; Hanson K; Goodman C
Malar J; 2017 May; 16(1):205. PubMed ID: 28526075
[TBL] [Abstract][Full Text] [Related]
12. Do anti-malarials in Africa meet quality standards? The market penetration of non quality-assured artemisinin combination therapy in eight African countries.
; Newton PN; Hanson K; Goodman C
Malar J; 2017 May; 16(1):204. PubMed ID: 28539125
[TBL] [Abstract][Full Text] [Related]
13. The Affordable Medicines Facility-malaria (AMFm): are remote areas benefiting from the intervention?
Ye Y; Arnold F; Noor A; Wamukoya M; Amuasi J; Blay S; Mberu B; Ren R; Kyobutungi C; Wekesah F; Gatakaa H; Toda M; Njogu J; Evance I; O'Connell K; Shewchuk T; Thougher S; Mann A; Willey B; Goodman C; Hanson K
Malar J; 2015 Oct; 14():398. PubMed ID: 26452625
[TBL] [Abstract][Full Text] [Related]
14. The malaria testing and treatment landscape in mainland Tanzania, 2016.
; Michael D; Mkunde SP
Malar J; 2017 Apr; 16(1):202. PubMed ID: 28521811
[TBL] [Abstract][Full Text] [Related]
15. Has Tanzania embraced the green leaf? Results from outlet and household surveys before and after implementation of the Affordable Medicines Facility-malaria.
Thomson R; Festo C; Johanes B; Kalolella A; Bruxvoort K; Nchimbi H; Tougher S; Cairns M; Taylor M; Kleinschmidt I; Ye Y; Mann A; Ren R; Willey B; Arnold F; Hanson K; Kachur SP; Goodman C
PLoS One; 2014; 9(5):e95607. PubMed ID: 24816649
[TBL] [Abstract][Full Text] [Related]
16. Experiences of healthcare personnel on the efficacy of artemisinin-based combination therapy and malaria diagnosis in hospitals in Uganda.
Ocan M; Bakubi R; Tayebwa M; Basemera J; Nsobya S
Malar J; 2023 Nov; 22(1):362. PubMed ID: 38012717
[TBL] [Abstract][Full Text] [Related]
17. Misuse of Artemisinin Combination Therapies by Clients of Medicine Retailers Suspected to Have Malaria Without Prior Parasitological Confirmation in Nigeria.
Nwokolo E; Ujuju C; Anyanti J; Isiguzo C; Udoye I; BongosIkwue E; Ezire O; Raji M; Oyibo WA
Int J Health Policy Manag; 2018 Jun; 7(6):542-548. PubMed ID: 29935131
[TBL] [Abstract][Full Text] [Related]
18. Effect of the Affordable Medicines Facility--malaria (AMFm) on the availability, price, and market share of quality-assured artemisinin-based combination therapies in seven countries: a before-and-after analysis of outlet survey data.
Tougher S; ; Ye Y; Amuasi JH; Kourgueni IA; Thomson R; Goodman C; Mann AG; Ren R; Willey BA; Adegoke CA; Amin A; Ansong D; Bruxvoort K; Diallo DA; Diap G; Festo C; Johanes B; Juma E; Kalolella A; Malam O; Mberu B; Ndiaye S; Nguah SB; Seydou M; Taylor M; Rueda ST; Wamukoya M; Arnold F; Hanson K
Lancet; 2012 Dec; 380(9857):1916-26. PubMed ID: 23122217
[TBL] [Abstract][Full Text] [Related]
19. The malaria testing and treatment landscape in Benin.
; Zinsou C; Cherifath AB
Malar J; 2017 Apr; 16(1):174. PubMed ID: 28446236
[TBL] [Abstract][Full Text] [Related]
20. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
